Table 2.
Peri-implant health status of the groups.
| Control |
T2DM |
||
|---|---|---|---|
| n (%) | n (%) | ||
| Implant diagnosis | Healthy | 20 (54.1%) | 11 (24.4%) |
| Peri-mucositis | 14 (37.8%) | 18 (40%) | |
| Peri-implantitis | 3 (8.1%) | 16 (35.6%) | |
| PI | 0 | 11 (29.7%) | 12 (26.7%) |
| 1 | 20 (54.1%) | 19 (42.2%) | |
| 2 | 2 (5.4%) | 14 (31.1%) | |
| 3 | 4 (10.8%) | 0 (0%) | |
| BOP | BOP (−) | 18 (48.6%) | 10 (22.2%) |
| BOP (+) | 19 (51.4%) | 35 (77.8%) | |
| PD | 0–3 mm | 14 (37.8%) | 10 (22.2%) |
| 4–6 mm | 20 (54.1%) | 26 (57.8%) | |
| >6 mm | 3 (8.1%) | 9 (20%) |
BOP, bleeding on probing; DM, diabetes mellitus; PD, pocket depth; PI, plaque index.